QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
What would you do in case of emergency?
Well, at Quantify our team knows exactly what to do following a great First Aid Training delivered by HLR-Gruppen Stockholm AB last Wednesday!
The training was very comprehensive both in theory and practice and equipped us well in how to act in case of an emergency, including CPR, how to use a defibrillator and performing the Heimlich maneuver.
Call on us to help you staying alive! ?
The black box grows larger…
The Dental and Pharmaceutical Benefits Agency, TLV is following the example of other Nordic countries – assessments involving secret prices will become more of a “black box”
Last week, TLV published a new standard procedure for assessing reimbursement status for pharmaceuticals where a confidential price has been negotiated for the comparator. Previously, due to TLV’s interpretation of “party insight,” the secret price of comparator could not be used […]
How much is TLV willing to pay for a QALY in Sweden?
Understanding how payers value a quality-adjusted life year (QALY) is crucial. We often are asked about the Swedish payer TLV’s willingness to pay (WTP) thresholds for one QALY, and whether the usually cited levels of WTP by severity are used in practice. Have another look at our ISPOR poster where we looked at 101 decisions since 2014 to see which incremental cost-effectiveness ratio (ICER) levels were accepted across […]
New study published on ICD-11 requirements
In Quantify’s latest publication co-authored by Christoph Abé, PhD, the research group conducted a field trial focused on the ICD-11 chapter on mental disorders which contains new diagnoses for impulse control disorders.
Using a vignette-based methodology, this field study examined the ability of more than 1,000 mental health professionals across the World Health Organization‘s Global Clinical Practice Network to apply the new […]